DE1380057U - - Google Patents

Info

Publication number
DE1380057U
DE1380057U DENDAT1380057D DE1380057DU DE1380057U DE 1380057 U DE1380057 U DE 1380057U DE NDAT1380057 D DENDAT1380057 D DE NDAT1380057D DE 1380057D U DE1380057D U DE 1380057DU DE 1380057 U DE1380057 U DE 1380057U
Authority
DE
Germany
Prior art keywords
lun
zur
app
der
ird
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1380057D
Other languages
German (de)
English (en)
Publication of DE1380057U publication Critical patent/DE1380057U/de
Active legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
DENDAT1380057D Active DE1380057U (https=)

Publications (1)

Publication Number Publication Date
DE1380057U true DE1380057U (https=)

Family

ID=692473

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1380057D Active DE1380057U (https=)

Country Status (1)

Country Link
DE (1) DE1380057U (https=)

Similar Documents

Publication Publication Date Title
Macdonald et al. Interleultin‐2 treatment‐associated eosinophilia is mediated by interleultin‐5 production
DE1380057U (https=)
CH650003A5 (de) Platin(iv)-diaminkomplexe, verfahren zu deren herstellung und diese enthaltende krebsmittel.
EP0527736A1 (de) Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung.
Pepeldjiyska et al. Leukemia derived dendritic cell (DCleu) mediated immune response goes along with reduced (leukemia-specific) regulatory T-cells
Flynn et al. Production of interleukin-1 and interleukin-2 in allogeneic mixed lymphocyte cultures under copper, magnesium and zinc deficient conditions
WO1991005558A1 (de) Verwendung von lecithin-analoga als antivirale arzneimittel sowie neue verbindungen
CA2274461A1 (en) Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia
DE3613447C2 (https=)
Kuroda et al. Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor T cells
Hu et al. The effect of valproic acid on SCE and chromosome aberrations in epileptic children
Ragab et al. The culture of colony forming units from the peripheral blood and bone marrow of children with acute lymphocytic leukemia
Jensen et al. Assessment of neuropathic pain
Sewell et al. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines
Tyulmenkova et al. Progressive generalized tonic-clonic seizures in a transgenic mouse model of adult-onset epilepsy: implications for morphological changes in cortico-limbic and brainstem structures
EP1686322A3 (de) Gargerät
Rüttinger et al. Adjuvante therapeutische Vakzinierung beim Lungenkarzinom: erste Ergebnisse einer klinischen Pilotstudie mit autologer Tumorzell-Impfung nach Lymphopenie-Induktion und Rekonstitution mit autologen T Lymphozyten
Ingalls Musculi sternales and infraclavicularis
Shin et al. Neural signatures of socially shaped self-worth: A meta-analysis
Etsten et al. Pattern of metabolic depression induced with pentothal sodium
KNOCK Chemotherapy of human cancer with sulfhydryl inhibitors
DE3730542A1 (de) Arzneimittel mit einem gehalt an bestimmten 6-mercaptopurin-derivaten, verwendung dieser 6-mercaptopurin-derivate, verfahren zur herstellung der arzneimittel sowie einige neue 6-mercaptopurin-derivate und verfahren zu deren herstellung
CN208943869U (zh) 一种对称式进出料混合装置
Almazov et al. Multiple Myeloma: Immunodeficient, Osteolytic, Renal, and Amyloid Syndromes
DE102021134472A1 (de) Vorrichtung zum Behandeln von Abgas II